ArticleBiology direct2026

Gene-guided repurposing identifies dihydroergotamine as a candidate inhibitor of the BCL2-SIVA1 axis in advanced gastric cancer in vitro.

Yu-Liang Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.